Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 6
2005 7
2006 11
2007 6
2008 11
2009 11
2010 14
2011 13
2012 15
2013 18
2014 12
2015 12
2016 11
2017 12
2018 19
2019 15
2020 13
2021 22
2022 21
2023 23
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi JFC, Ferreira FR, Silva-Amaral D, Lima DA, Hallak JEC, Zuardi AW, Del-Bel EA, Guimarães FS, Costa KCM, Campos AC, Crippa ACS, Crippa JAS. Pedrazzi JFC, et al. Among authors: guimaraes fs. Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29. Psychopharmacology (Berl). 2022. PMID: 35904579 Review.
Neuroanatomy of anxiety.
Canteras NS, Resstel LB, Bertoglio LJ, Carobrez Ade P, Guimarães FS. Canteras NS, et al. Curr Top Behav Neurosci. 2010;2:77-96. doi: 10.1007/7854_2009_7. Curr Top Behav Neurosci. 2010. PMID: 21309107 Review.
Hemopressin as a breakthrough for the cannabinoid field.
Heimann AS, Dale CS, Guimarães FS, Reis RAM, Navon A, Shmuelov MA, Rioli V, Gomes I, Devi LL, Ferro ES. Heimann AS, et al. Among authors: guimaraes fs. Neuropharmacology. 2021 Feb 1;183:108406. doi: 10.1016/j.neuropharm.2020.108406. Epub 2020 Nov 16. Neuropharmacology. 2021. PMID: 33212113 Free PMC article. Review.
Cannabinoid Modulation of the Stressed Hippocampus.
Scarante FF, Vila-Verde C, Detoni VL, Ferreira-Junior NC, Guimarães FS, Campos AC. Scarante FF, et al. Among authors: guimaraes fs. Front Mol Neurosci. 2017 Dec 19;10:411. doi: 10.3389/fnmol.2017.00411. eCollection 2017. Front Mol Neurosci. 2017. PMID: 29311804 Free PMC article. Review.
Cannabidiol, neuroprotection and neuropsychiatric disorders.
Campos AC, Fogaça MV, Sonego AB, Guimarães FS. Campos AC, et al. Among authors: guimaraes fs. Pharmacol Res. 2016 Oct;112:119-127. doi: 10.1016/j.phrs.2016.01.033. Epub 2016 Feb 1. Pharmacol Res. 2016. PMID: 26845349 Review.
Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556.
Colodete DAE, Silva NR, Pedrazzi JFC, Fogaça MV, Cortez I, Del-Bel EA, Breuer A, Mechoulam R, Gomes FV, Guimarães FS. Colodete DAE, et al. Among authors: guimaraes fs. Behav Pharmacol. 2023 Jun 1;34(4):213-224. doi: 10.1097/FBP.0000000000000727. Epub 2023 May 10. Behav Pharmacol. 2023. PMID: 37171460
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Cortez IL, Rodrigues da Silva N, Guimarães FS, Gomes FV. Cortez IL, et al. Among authors: guimaraes fs. Front Psychiatry. 2020 Oct 30;11:587154. doi: 10.3389/fpsyt.2020.587154. eCollection 2020. Front Psychiatry. 2020. PMID: 33329132 Free PMC article. Review.
239 results